Citation: Gjp. Singh et al., EVALUATION OF THE PROPOSED FDA PILOT DOSE-RESPONSE METHODOLOGY FOR TOPICAL CORTICOSTEROID BIOEQUIVALENCE TESTING, Pharmaceutical research, 15(1), 1998, pp. 4-5
Authors:
SINGH GJP
LESKO LJ
SHAH VP
ADAMS WP
MOLZON JA
WILLIAMS RL
PERSHING LK
Citation: Gjp. Singh et al., PHARMACODYNAMIC (PD) MODELING TO DEVELOP BIOEQUIVALENCE (BE) METHODOLOGY FOR DERMATOLOGICAL CORTICOSTEROIDS (DCS), Clinical pharmacology and therapeutics, 57(2), 1995, pp. 181-181
Authors:
ADAMS WP
SINGH GJP
MOLZON JA
KATZPER M
MARTINEZ MN
WILLIAMS RL
CRETICOS PS
PETTY BG
KHATTIGNAVONG A
LIETMAN PS
Citation: Wp. Adams et al., DEVELOPMENT OF PHARMACODYNAMIC METHODOLOGY FOR DETERMINATION OF ALBUTEROL MDI BIOEQUIVALENCE - SINGLE DOSE SEPARATE DAYS AND CUMULATIVE DOSE BRONCHODILATOR STUDIES/, Journal of allergy and clinical immunology, 93(1), 1994, pp. 249-249
Authors:
CRETICOS PS
PETTY BG
KHATTIGNAVONG A
LIETMAN PS
ADAMS WP
SINGH GJP
MOLZON JA
MARTINEZ MN
WILLIAMS RL
Citation: Ps. Creticos et al., DEVELOPMENT OF PHARMACODYNAMIC METHODOLOGY FOR DETERMINATION OF ALBUTEROL MDI BIOEQUIVALENCE - METHACHOLINE CHALLENGE STUDY, Journal of allergy and clinical immunology, 93(1), 1994, pp. 249-249